We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Approves Roche's Avastin for Advanced Cervical Cancer
EU Approves Roche's Avastin for Advanced Cervical Cancer
The European Commission has approved Roche's Avastin plus chemotherapy for women with persistent, recurrent or metastatic cervical cancer, the company said Wednesday.